Blog

All the latest news from Check4Cancer
Check4Cancer launches new London ‘OneStop Breast Clinic’ for younger patients who will no longer be seen in NHS breast clinics.
Professor Gordon Wishart, Chief Medical Officer of Check4Cancer launches a private ‘OneStop Breast Clinic’ for younger pa...
Who is at risk of bowel cancer?
  Bowel cancer is the fourth most common cancer in the UK and the second biggest cancer killer, but it shouldn’t be.&...
How can you get tested for prostate cancer?
Prostate cancer survival is improving and has tripled in the last 40 years in the UK, probably because of PSA testing[1]. Whe...
Why should you check for prostate cancer?
Prostate cancer is the most common cancer in men, however it’s often symptomless in its early stages. In our third blog for...
What are the symptoms of prostate cancer?
More than 47,000 men are diagnosed with prostate cancer in the UK every year– that’s around 130 every day[1]. Prostate ca...
Who is at risk of prostate cancer?
March is Prostate Cancer Awareness Month. In recognition of this, Check4Cancer is sharing a series of blogs exploring the WHO...
World Cancer Day - raising awareness of cancer prevention
  Tuesday 4th February is World Cancer Day, Professor Gordon Wishart, our Chief Executive Officer and Chief Medical Off...
Cancer Research UK highlight a 54% increase in cervical cancer rates in women aged 25-29
Professor Gordon Wishart, our CEO and Chief Medical Officer comments on the 54% increase in cervical cancer rates in women ag...
Experts say that Cervical Cancer could be eliminated in England
The Guardian has reported today that experts say that cervical cancer could be eliminated in England. Vaccination and HPV scr...
Professor Gordon Wishart listed on #21toWatch People longlist
Professor Gordon Wishart listed on #21toWatch People longlist 
The pitfalls of direct-to-consumer (DTC) cancer genetic testing
The pitfalls of direct-to-consumer (DTC) cancer genetic testing
Breast cancer facts October 2019
UK is bottom of international league tables for cancer survival
Investing in early cancer diagnosis can play a big part in closing the survival gap.
New blood test catches lung cancer early
A Scottish landmark research study presented this week at the 2019 World Conference on Lung Cancer has confirmed that the Ear...
UK Skin cancer incidence risen 45% in 10 years
Cancer Research UK has recently reported that the incidence of melanoma, the most serious type of skin cancer, has risen by 4...
Cervical screening awareness week June 2019
Cervical cancer is nearly always preventable. HPV (Human papillomavirus) is a sexually transmitted virus that is extremely co...
Annual screening detects breast cancers earlier for women aged 35-39 with a family history
First long-term study (FH02) from University of Manchester confirming effectiveness of annual screening mammography&nb...
Check4Cancer launches innovative prostate cancer diagnosis pathway with AXA PPP healthcare
Prostate cancer is the most common cancer in men, with 1 in 8 diagnosed at some point in their lives. Indeed, with Men...
PREDICT model wins research excellence award
The PREDICT breast cancer survival and treatment prediction model won the People's Choice Award at the Office for National St...
2018 Finalist - Innovators and Leaders - LaingBuisson Awards
A finalist in the 'Rising Star' category of the LaingBuisson Health & Care Awards 2018.  Under Professor Gordon Wish...
Home HPV tests as good as clinician collected cervical samples
A recent US study published in Obstetrics & Gynecology has confirmed the prevalence of high-risk HPV types detected by se...
AXA PPP enhances prostate cancer diagnosis pathway
AXA PPP healthcare has teamed up with screening service, Check4Cancer, to enhance its prostate cancer diagnosis pathway. ...
Evidence led services impress the judges at the Health Investor Awards
It was third time lucky for Check4Cancer at the Health Investor Awards earlier this month.
Clinical excellence in One Stop pathway audit data presented at Association of Breast Surgery Conference
Professor Gordon Wishart, Chief Medical Officer of Check4Cancer, presents audit results from its private breast can...